Immuneering Operating Income from 2010 to 2026
| IMRX Stock | USD 5.00 0.25 4.76% |
Operating Income | First Reported 2020-03-31 | Previous Quarter -14.8 M | Current Value -15.4 M | Quarterly Volatility 4.5 M |
Check Immuneering Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immuneering Corp's main balance sheet or income statement drivers, such as Net Interest Income of 3.1 M, Interest Income of 3.1 M or Depreciation And Amortization of 233 K, as well as many indicators such as Price To Sales Ratio of 382, Dividend Yield of 0.0 or PTB Ratio of 1.51. Immuneering financial statements analysis is a perfect complement when working with Immuneering Corp Valuation or Volatility modules.
Immuneering | Operating Income | Build AI portfolio with Immuneering Stock |
The evolution of Operating Income for Immuneering Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Immuneering Corp compares to historical norms and industry peers.
Latest Immuneering Corp's Operating Income Growth Pattern
Below is the plot of the Operating Income of Immuneering Corp over the last few years. Operating Income is the amount of profit realized from Immuneering Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Immuneering Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Immuneering Corp's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immuneering Corp's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Immuneering Operating Income Regression Statistics
| Arithmetic Mean | (23,901,156) | |
| Coefficient Of Variation | (100.93) | |
| Mean Deviation | 21,520,003 | |
| Median | (6,291,014) | |
| Standard Deviation | 24,122,400 | |
| Sample Variance | 581.9T | |
| Range | 57.8M | |
| R-Value | (0.87) | |
| Mean Square Error | 155.6T | |
| R-Squared | 0.75 | |
| Slope | (4,135,146) | |
| Total Sum of Squares | 9310.2T |
Immuneering Operating Income History
Other Fundumenentals of Immuneering Corp
Immuneering Corp Operating Income component correlations
Click cells to compare fundamentals
About Immuneering Corp Financial Statements
Immuneering Corp investors use historical fundamental indicators, such as Immuneering Corp's Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immuneering Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Income | -57.7 M | -60.5 M | |
| Non Operating Income Net Other | 1.4 M | 1.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.